Braxia Scientific Corp
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery metho… Read more
Braxia Scientific Corp (BRAXF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2023: 1.456x
Based on the latest financial reports, Braxia Scientific Corp (BRAXF) has a cash flow conversion efficiency ratio of 1.456x as of December 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-532.56K) by net assets ($-365.84K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Braxia Scientific Corp - Cash Flow Conversion Efficiency Trend (2020–2023)
This chart illustrates how Braxia Scientific Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Braxia Scientific Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Braxia Scientific Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ARTPRICE COM (AJP.SG)
STU:AJP
|
N/A |
|
SINGTEL 1000
BE:SIT4
|
0.063x |
|
ACRO Biomedical Co Ltd
PINK:ACBM
|
0.126x |
|
AUSTOCK GRP
BE:5A9
|
N/A |
|
AMERN VANGUARD CORP
BE:AVJ
|
-0.040x |
|
Riverwalk Acquisition Corp.
V:RAC-P
|
-0.173x |
|
S&U plc
LSE:SUS
|
0.051x |
|
METSA BOARD -B-
BE:MSRB
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Braxia Scientific Corp (2020–2023)
The table below shows the annual cash flow conversion efficiency of Braxia Scientific Corp from 2020 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-03-31 | $1.60 Million | $-7.40 Million | -4.611x | -814.59% |
| 2022-03-31 | $8.96 Million | $-4.52 Million | -0.504x | -58.43% |
| 2021-03-31 | $15.89 Million | $-5.06 Million | -0.318x | -1441.65% |
| 2020-03-31 | $13.99 Million | $-288.83K | -0.021x | -- |